Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Helminth | 1 | 2025 | 4 | 0.920 |
Why?
|
| Genome | 2 | 2023 | 149 | 0.920 |
Why?
|
| Rotifera | 1 | 2025 | 13 | 0.910 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2024 | 2 | 0.860 |
Why?
|
| Chromosomes | 1 | 2023 | 44 | 0.820 |
Why?
|
| Mucin-1 | 1 | 2021 | 11 | 0.700 |
Why?
|
| Cyperaceae | 1 | 2020 | 2 | 0.670 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2020 | 65 | 0.640 |
Why?
|
| Ducks | 3 | 2023 | 29 | 0.560 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2025 | 30 | 0.440 |
Why?
|
| Glycosylation | 2 | 2024 | 111 | 0.380 |
Why?
|
| Protein Isoforms | 2 | 2024 | 139 | 0.370 |
Why?
|
| Escherichia coli | 2 | 2025 | 461 | 0.360 |
Why?
|
| Ribosome Subunits, Large, Bacterial | 2 | 2025 | 2 | 0.290 |
Why?
|
| Escherichia coli Proteins | 2 | 2025 | 133 | 0.260 |
Why?
|
| North America | 2 | 2023 | 85 | 0.250 |
Why?
|
| Genomics | 3 | 2023 | 289 | 0.250 |
Why?
|
| Arthritis, Experimental | 1 | 2025 | 8 | 0.240 |
Why?
|
| Neuropeptide Y | 1 | 2025 | 26 | 0.230 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2025 | 36 | 0.230 |
Why?
|
| Sirolimus | 1 | 2025 | 70 | 0.230 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2025 | 53 | 0.230 |
Why?
|
| Body Size | 1 | 2025 | 47 | 0.220 |
Why?
|
| Chromatiaceae | 1 | 2024 | 1 | 0.220 |
Why?
|
| Autotrophic Processes | 1 | 2024 | 2 | 0.220 |
Why?
|
| Sulfur | 1 | 2024 | 21 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 88 | 0.220 |
Why?
|
| Sulfides | 1 | 2024 | 77 | 0.210 |
Why?
|
| Leukemia | 1 | 2023 | 54 | 0.200 |
Why?
|
| Interleukin-2 | 1 | 2023 | 90 | 0.190 |
Why?
|
| Iron | 1 | 2024 | 247 | 0.190 |
Why?
|
| Humans | 13 | 2024 | 42163 | 0.190 |
Why?
|
| Animals | 6 | 2025 | 16695 | 0.180 |
Why?
|
| Pyrazoles | 1 | 2022 | 93 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 40 | 0.170 |
Why?
|
| Phylogeny | 1 | 2025 | 740 | 0.170 |
Why?
|
| Receptors, CCR5 | 2 | 2018 | 64 | 0.170 |
Why?
|
| Peptides | 1 | 2024 | 357 | 0.170 |
Why?
|
| Sequence Analysis, Protein | 1 | 2020 | 51 | 0.170 |
Why?
|
| Extreme Heat | 1 | 2020 | 4 | 0.170 |
Why?
|
| Arctic Regions | 1 | 2020 | 21 | 0.170 |
Why?
|
| Alaska | 1 | 2020 | 61 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 139 | 0.160 |
Why?
|
| HIV-1 | 2 | 2018 | 747 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2022 | 683 | 0.160 |
Why?
|
| Animals, Wild | 1 | 2020 | 24 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 729 | 0.160 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 5 | 0.160 |
Why?
|
| Flavivirus | 1 | 2019 | 16 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2025 | 2111 | 0.150 |
Why?
|
| HIV Long-Term Survivors | 1 | 2018 | 7 | 0.150 |
Why?
|
| Temperature | 1 | 2020 | 314 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2018 | 36 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 203 | 0.140 |
Why?
|
| Algorithms | 1 | 2020 | 508 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 330 | 0.130 |
Why?
|
| Virus Replication | 1 | 2019 | 318 | 0.130 |
Why?
|
| RNA, Bacterial | 2 | 2025 | 38 | 0.110 |
Why?
|
| Bystander Effect | 1 | 2012 | 15 | 0.100 |
Why?
|
| Hybridization, Genetic | 2 | 2023 | 24 | 0.090 |
Why?
|
| HIV Infections | 2 | 2018 | 2535 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2023 | 973 | 0.080 |
Why?
|
| Autophagy | 2 | 2025 | 136 | 0.080 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2018 | 7 | 0.060 |
Why?
|
| RNA, Ribosomal | 1 | 2025 | 30 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2025 | 72 | 0.060 |
Why?
|
| Apoptosis | 1 | 2012 | 1541 | 0.060 |
Why?
|
| Photosynthesis | 1 | 2024 | 34 | 0.050 |
Why?
|
| Electrons | 1 | 2024 | 74 | 0.050 |
Why?
|
| RNA, Ribosomal, 23S | 1 | 2023 | 5 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2023 | 6 | 0.050 |
Why?
|
| Ribosomes | 1 | 2023 | 34 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 19 | 0.050 |
Why?
|
| Breeding | 1 | 2023 | 28 | 0.050 |
Why?
|
| Europe | 1 | 2023 | 114 | 0.050 |
Why?
|
| Janus Kinase 1 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Janus Kinase 3 | 1 | 2023 | 36 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 22 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 21 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2022 | 157 | 0.050 |
Why?
|
| Exocytosis | 1 | 2022 | 49 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2022 | 89 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 78 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2022 | 147 | 0.040 |
Why?
|
| Caspases | 1 | 2022 | 148 | 0.040 |
Why?
|
| Tubulin | 1 | 2022 | 94 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2022 | 420 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 387 | 0.040 |
Why?
|
| Microtubules | 1 | 2022 | 120 | 0.040 |
Why?
|
| Cell Death | 1 | 2022 | 277 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2022 | 462 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 284 | 0.040 |
Why?
|
| Databases, Protein | 1 | 2020 | 54 | 0.040 |
Why?
|
| Binding Sites | 1 | 2022 | 670 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 262 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 286 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2022 | 348 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 228 | 0.040 |
Why?
|
| Gene Flow | 1 | 2020 | 29 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.040 |
Why?
|
| RNA Viruses | 1 | 2019 | 22 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2019 | 29 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 580 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 255 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 482 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 518 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 189 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2019 | 118 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 188 | 0.040 |
Why?
|
| Protein Binding | 1 | 2022 | 1076 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2022 | 875 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1188 | 0.030 |
Why?
|
| Cell Movement | 1 | 2022 | 640 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 698 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 200 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 508 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 1169 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 692 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 933 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1420 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1416 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2598 | 0.030 |
Why?
|
| Mice | 1 | 2025 | 6490 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2012 | 12 | 0.020 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 17 | 0.020 |
Why?
|
| Male | 2 | 2025 | 22779 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 74 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 661 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1554 | 0.020 |
Why?
|
| Female | 1 | 2022 | 24018 | 0.010 |
Why?
|